These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21477942)

  • 1. Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
    Jonsson JH; Garpebring A; Karlsson MG; Nyholm T
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1612-8. PubMed ID: 21477942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
    Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
    Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
    Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
    Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
    Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
    Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
    Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
    Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
    Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
    Gustafsson C; Persson E; Gunnlaugsson A; Olsson LE
    J Appl Clin Med Phys; 2018 Nov; 19(6):185-192. PubMed ID: 30354010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
    Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
    Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
    Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
    Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative evaluation of fiducial markers for radiotherapy imaging.
    Chan MF; Cohen GN; Deasy JO
    Technol Cancer Res Treat; 2015 Jun; 14(3):298-304. PubMed ID: 25230715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
    Gustafsson C; Korhonen J; Persson E; Gunnlaugsson A; Nyholm T; Olsson LE
    Med Phys; 2017 Nov; 44(11):5563-5574. PubMed ID: 28803447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
    Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
    J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of multiorgan finite element-based prostate deformation model enabling registration of endorectal coil magnetic resonance imaging for radiotherapy planning.
    Hensel JM; Ménard C; Chung PW; Milosevic MF; Kirilova A; Moseley JL; Haider MA; Brock KK
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1522-8. PubMed ID: 17674983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
    Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
    Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position verification for the prostate: effect on rectal wall dose.
    Haverkort MA; van de Kamer JB; Pieters BR; van Tienhoven G; Assendelft E; Lensing AL; van Herk M; de Reijke TM; Stoker J; Koning CC
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):462-8. PubMed ID: 20646865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
    Deutschmann H; Kametriser G; Steininger P; Scherer P; Schöller H; Gaisberger C; Mooslechner M; Mitterlechner B; Weichenberger H; Fastner G; Wurstbauer K; Jeschke S; Forstner R; Sedlmayer F
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1624-32. PubMed ID: 22209149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
    Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis.
    Tyagi N; Fontenla S; Zhang J; Cloutier M; Kadbi M; Mechalakos J; Zelefsky M; Deasy J; Hunt M
    Phys Med Biol; 2017 Apr; 62(8):2961-2975. PubMed ID: 27983520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of gold fiducial markers in the prostate using phase-cycled bSSFP imaging for MRI-only radiotherapy.
    Shcherbakova Y; Bartels LW; Mandija S; Beld E; Seevinck PR; van der Voort van Zyp JRN; Kerkmeijer LGW; Moonen CTW; Lagendijk JJW; van den Berg CAT
    Phys Med Biol; 2019 Sep; 64(18):185001. PubMed ID: 31344696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.